Windlas Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
828.00
-55.65 (-6.3%)
BSENSE

Aug 10

BSE+NSE Vol: 1.2 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003519,
    "name": "Windlas Biotech",
    "stock_name": "Windlas Biotech",
    "full_name": "Windlas Biotech Ltd",
    "name_url": "stocks-analysis/windlas-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "828.00",
    "chg": -55.65,
    "chgp": "-6.3%",
    "dir": -1,
    "prev_price": "883.65",
    "mcapval": "1,821.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543329,
    "symbol": "WINDLAS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0H5O01029",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "1.2 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/windlas-biotech-1003519-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "1003519",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/windlas-biotech-1003519"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Aug-2026",
      "details": "Schedule of Conference Call to discuss financial performance for quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Aug-2026",
      "details": "Schedule of Conference Call to discuss financial performance for quarter ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Monday August 10 2026",
      "datetime": "04-Aug-2026",
      "details": "Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Notice is hereby given that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Monday August 10 2026 inter alia to consider and approve the un-audited standalone financial results for the quarter ended June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Windlas Biotech Ltd has declared <strong>126%</strong> dividend, ex-date: 16 Jul 26",
          "dt": "2026-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Aug-2026 | Source : BSE

Schedule of Conference Call to discuss financial performance for quarter ended June 30 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05-Aug-2026 | Source : BSE

Schedule of Conference Call to discuss financial performance for quarter ended June 30 2026

Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Monday August 10 2026

04-Aug-2026 | Source : BSE

Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Notice is hereby given that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of the Company is scheduled to be held on Monday August 10 2026 inter alia to consider and approve the un-audited standalone financial results for the quarter ended June 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Windlas Biotech Ltd has declared 126% dividend, ex-date: 16 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available